用于皮肤炎治疗的环素A装载溶解微针:在延迟型过敏体内模型中的发展,特征和有效性
Miquel Martínez-Navarrete1, Antonio José Guillot2,3, Maria C Lobita4
1Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Ave. Vicent Andrés Estellés s/n, 46100, Burjassot, Valencia, Spain.
Drug delivery and translational research
|March 13, 2024
概括
本研究介绍了一种使用脂质囊泡和溶解微针贴片的新型纳米在微设备,用于增强局部递送环素A (CsA). 在微针贴片中开发的CsA脂囊有效治疗皮肤炎症,为皮质类固醇提供了一个有希望的替代品.
科学领域:
- 皮肤病学和纳米技术
- 药物输送系统 药物输送系统
- 免疫学 免疫学 免疫学
背景情况:
- 在慢性炎症性皮肤疾病 (如皮肤炎和牛皮) 中,优选局部药物输送,以避免系统性副作用.
- 环素A (CsA) 是一种潜在的治疗剂,但其高分子量阻碍了有效的皮肤透.
- 需要新的交付系统来克服传统局部CSA管理的局限性.
研究的目的:
- 开发和评估一种纳米在微设备,结合脂质囊泡 (LVs) 和溶解微针阵列补丁 (DMAPs),以增强局部递送环素A (CsA).
- 在DMAP中评估CSA载体LVs在治疗皮肤炎症疾病中的有效性.
主要方法:
- CsA被封装成脂质囊泡 (LVs).
- CsA-LVs被纳入溶解微针阵列补丁 (DMAP) 矩阵中.
- 试验室安全性和生物相容性在HaCaT角质细胞和L929纤维细胞上进行了测试.
- 使用弗朗茨扩散细胞进行了ex vivo皮肤透性研究.
- 活体内疗效在推迟型过敏的小鼠模型中进行了评估.
主要成果:
- CsA-LVs@DMAPs表现出足够的机械性能可以穿透皮肤.
- 在体外试验证实了配方的安全性和生物相容性.
- 活体研究表明,皮肤层内有效保留药物.
- 在体内研究显示,炎症减少,组织结构正常化,炎症性细胞因子减少,表明治疗潜力.
- 生物发光成像显示光子发射减少,证实了抗炎作用.
结论:
- 开发的CsA-LVs@DMAP有效地通过皮肤传递CsA,降低皮肤炎症环境的调节.
- 这种新的纳米微系统显示出治疗炎症性皮肤疾病的巨大潜力.
- CsA-LVs@DMAPs为皮肤炎和牛皮等疾病的皮质类固醇治疗提供了一个有希望的替代方案.
相关概念视频
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...